Electrocore LLC

Yahoo Finance • 9 days ago

electroCore files to sell 763K shares of common stock for holders

* electroCore (NASDAQ:ECOR [https://seekingalpha.com/symbol/ECOR]) has filed to sell 762,508 shares of common stock for holders. * This prospectus is not an offer to sell these securities. * Filing [https://seekingalpha.com/filing/10... Full story

Yahoo Finance • 9 days ago

electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)

ROCKAWAY, N.J., Oct. 03, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that Jennifer Hayes will be joining electroCore, effecti... Full story

Yahoo Finance • last month

Ecora Resources PLC to Present at the European Growth Virtual Investor Conference September 11th

LONDON, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Ecora Resources PLC (LSE/TSX: ECOR, OTCQX: ECRAF), the London based critical minerals royalty and streaming company, announces that Geoff Callow, Head of Investor Relations, will present live at... Full story

Yahoo Finance • last month

electroCore Announces Departure of Peter Cuneo from the Board of Directors and Elects Thomas J. Errico, MD as Chairman of the Board

ROCKAWAY, N.J., Sept. 05, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today the departure of Peter Cuneo from the Board of Directors and that Thomas... Full story

Yahoo Finance • last month

electroCore Partners with iHeartRadio and Former New York Jets Star Linebacker Greg Buttle to Champion Better Sleep and Stress Relief

ROCKAWAY, N.J., Sept. 04, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today its partnership with Greg Buttle, former New York Jets linebacker and NF... Full story

Yahoo Finance • 2 months ago

electroCore names Kelly Benning as SVP of Truvaga wellness division

ROCKAWAY, N.J. - electroCore, Inc. (NASDAQ:ECOR), a bioelectronic medicine company with a market capitalization of $32.68 million, has appointed Kelly Benning as Senior Vice President of its consumer wellness division, Truvaga, effective J... Full story

Yahoo Finance • 2 months ago

ELECTROCORE INC (NASDAQ:ECOR) Reports Mixed Q2 2025 Earnings with Revenue Beat but Wider-Than-Expected Loss

ELECTROCORE INC (NASDAQ:ECOR [https://www.chartmill.com/stock/quote/ECOR]) reported its second-quarter 2025 financial results, revealing mixed performance relative to analyst expectations. While revenue slightly surpassed estimates, the co... Full story

Yahoo Finance • 2 months ago

electroCore Announces Second Quarter 2025 Financial Results

Net sales of $7.4 million increased 20% vs. Q2’2024; YTD net sales of $14.1 million increased 22% vs. first half of 2024 Cash, cash equivalents, restricted cash, and marketable securities of $7.4 million as of June 30, 2025 Company to ho... Full story

Yahoo Finance • 2 months ago

electroCore Appoints James C. Theofilos to the Board of Directors

electroCore, Inc. ROCKAWAY, N.J., Aug. 05, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that James C. Theofilos has been appointed to the Board... Full story

Yahoo Finance • 3 months ago

electroCore to Participate in Upcoming Investor Conferences

ROCKAWAY, N.J., July 22, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate in the following investor conferences.... Full story

Yahoo Finance • 5 months ago

electroCore, Inc. (ECOR): A Bull Case Theory

We came across a bullish thesis on electroCore, Inc. (ECOR) on Twitter by KyleAdamsStocks. In this article, we will summarize the bulls’ thesis on ECOR. electroCore, Inc. (ECOR)'s share was trading at $6.85 as of May 2nd.Worst States for D... Full story

Yahoo Finance • 6 months ago

gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Shown to be Effective in Treating Concussive Symptoms Associated with Mild Traumatic Brain Injuries

ROCKAWAY, N.J., April 17, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that new data presented at the 2025 International Brain Injury Associati... Full story

Yahoo Finance • 6 months ago

electroCore to Participate at the Needham Virtual Healthcare Conference

ROCKAWAY, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate at the Needham Virtual Healthcare Confe... Full story

Yahoo Finance • 7 months ago

electroCore Announces Full Year 2024 Financial Results

Record full year 2024 net sales of $25.2 million increased 57% over $16.0 million for the full year 2023 driven by 85% annual growth of Rx gammaCoreTMin the United States Department of Veteran Affairs and United States Department of Defens... Full story

Yahoo Finance • 7 months ago

electroCore to Participate at Upcoming Investor Conferences

ROCKAWAY, N.J., March 05, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate in two upcoming investor conferences. M... Full story

Yahoo Finance • 2 years ago

Dr. Peter Staats to Host Analyst Day on the Science Behind gammaCore™ Non-Invasive Vagus Nerve Stimulation (nVNS) on Tuesday, November 21, 2023

ROCKAWAY, N.J., Nov. 15, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that the Company’s Chief Medical Officer, Dr. Peter Staats will host an a... Full story

Yahoo Finance • 2 years ago

electroCore Announces Third Quarter 2023 Financial Results

Record third quarter 2023 net sales of $4.5 million, an increase of approximately 128% over third quarter 2022 Company increases revenue guidance for full year 2023 to $15.0 million - $15.5 million Company to host a conference call and... Full story

Yahoo Finance • 2 years ago

electroCore to Participate in Canaccord Genuity’s MedTech, Diagnostics and Digital Health & Services Forum

ROCKAWAY, N.J., Nov. 07, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Company CEO, Dan Goldberger, is scheduled to attend the Canaccord Ge... Full story

Yahoo Finance • 2 years ago

Data Highlighting Non-invasive Vagus Nerve Stimulation (nVNS) for Treatment of Symptoms of Gastroparesis Presented at 2023 American College of Gastroenterology Annual Meeting

ROCKAWAY, N.J., Oct. 24, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced top line data from an abstract being presented as an oral podium presenta... Full story

Yahoo Finance • 2 years ago

electroCore Announces Two-Year Extension of gammaCore™ Device Listing in the NHS Supply Chain Catalogue

ROCKAWAY, N.J., Oct. 17, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial stage bioelectronic medicine and wellness company, announced today that gammaCore therapy will continue to be listed in the United Kingdom’s... Full story